Abstract:The purpose of this prospective, randomized, double blind study was to compare the onset and duration periods of pulpal anesthesia using 2% lidocaine with 1:100,000 epinephrine, 4% articaine with 1:100,000 epinephrine and 4% articaine with 1:200,000 epinephrine in inferior alveolar nerve block (IANB). Thirty subjects received 1.8 mL of each of the three local anesthetic solutions in IANB. Onset and duration periods of pulpal anesthesia were determined using electric pulp stimulation. The mean time of onset of … Show more
“…Articaine is an anesthetic solution that was approved by the Food and Drug Administration for use in dentistry in the United States in 2000 (13). Articaine is claimed to provide faster onset and longer duration of pulp anesthesia compared with lidocaine (14). Several investigations have compared the anesthetic efficacy of articaine with other anesthetic agents (15)(16)(17)(18)(19).…”
Increasing the volume of articaine provided a significantly higher success rate of IANBs in mandibular first molar teeth with symptomatic irreversible pulpitis, but it did not result in 100% anesthetic success.
“…Articaine is an anesthetic solution that was approved by the Food and Drug Administration for use in dentistry in the United States in 2000 (13). Articaine is claimed to provide faster onset and longer duration of pulp anesthesia compared with lidocaine (14). Several investigations have compared the anesthetic efficacy of articaine with other anesthetic agents (15)(16)(17)(18)(19).…”
Increasing the volume of articaine provided a significantly higher success rate of IANBs in mandibular first molar teeth with symptomatic irreversible pulpitis, but it did not result in 100% anesthetic success.
“…Thereby, it penetrates the nerve membrane more easily and also due to a lower dissociation constant (pKa-7.8) of articaine which is comparable to lignocaine(pKa-7.9) which results in large number of lipophilic free base molecules that are able to diffuse through the nerve sheath thereby lowering the onset time (6,10,11). These characteristics also result in shorter time of onset of hard and soft tissue anaesthesia with articaine (12,13) The present study coincided with the study of Sierra-Rebolledo A et Al (14) who found the difference between the mean subjective onset between 4% articaine with 1:100000 adrenaline and 2% lignocaine with 1:100000 adrenaline to be 19 seconds with articaine having a shorter onset of anesthesia. Martinez-Rodriguez N et al (15) reported latency period of 1.04 min and 3.75 min respectively for Articaine and Lignocaine with the difference being more than 2 minutes with articaine having a shorter onset time.…”
Section: A Comparative Evaluation Of the Efficacy Of 4% Articaine (1:mentioning
“…37 Articaine is an anesthetic solution that was approved by the Food and Drug Administration for use in dentistry in the United States in 2000. 38 Articaine is claimed to provide faster onset and longer duration of pulp anesthesia compared with lidocaine. 39 Several investigations have compared the anesthetic efficacy of articaine with other anesthetic agents.…”
mentioning
confidence: 99%
“…39 Several investigations have compared the anesthetic efficacy of articaine with other anesthetic agents. [40][41][42][43][44][45] The results of these studies have shown no significant difference between articaine and lidocaine when used for IANB injections. 40 [46][47] A second molecular difference is the ester linkage incorporated into the articaine molecule, which results in hydrolysis of articaine by plasma esterase"s. Ninety to 95 percent of articaine is metabolized in the blood by plasma esterase"s, with the remainder being broken down in the liver, 46 whereas approximately 90 percent of lidocaine is metabolized by the liver.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.